Shibata K, Mita I, Shinoda Y, Nakano U, Kinoshita H, Noguchi M, Uzawa T, Sohmiya Y, Takayanagi N
Jpn J Antibiot. 1987 Jan;40(1):145-69.
General pharmacological properties of isepamicin sulfate (HAPA-B), a new aminoglycoside antibiotic, were studied in animals and the results obtained were summarized below. Intramuscular injections of HAPA-B at doses of 500 mg/kg inhibited the writing response induced by acetic acid, and at doses of 1,000 mg/kg, caused muscle relaxation, respiratory depression, suppression of spontaneous motor activity and prolongation of thiopental anesthesia. Anticonvulsive action and the effect on the rectal temperature were not observed. Intravenous Intravenous HAPA-B showed no significant effect on the general behavior and the function of the central nervous system at doses of 100 mg/kg. Intravenous injections of HAPA-B to anesthetized dogs resulted increases in the femoral arterial blood flow at doses of 12.5 mg/kg, decrease in the blood pressure and increase in the respiratory rate at doses of 25 mg/kg, and increase in the carotid arterial blood flow at doses of 50 mg/kg. Apparent changes were not recognized in the heart rate and electrocardiograms. In conscious rabbits, intravenous HAPA-B produced increases in the heart rate without significant changes of the blood pressure and electrocardiograms at doses of 100 mg/kg. Spontaneous beatings of isolated atria were depressed by HAPA-B in concentrations of 3 X 10(-4) to 10(-3) g/ml. The HAPA-B inhibited the gastric secretion at intramuscular doses of 500 mg/kg or intravenous doses of 100 mg/kg, and depressed charcoal transport through small intestine and the spontaneous movement of isolated ileum at intramuscular doses of 1,000 mg/kg and at concentrations of 3 X 10(-4) to 10(-3) g/ml, respectively. No irritative effect was found on the gastric mucous membrane. Intravenous HAPA-B inhibited the response of nictitating membrane to pre and post ganglionic stimulations of cervical sympathetic nerve at doses of 100 mg/kg. In in vitro test, HAPA-B inhibited nonspecifically the constrictive responses of trachea, aorta, stomach, ileum and vas deferens to various agonists in concentrations of 3 X 10(-4) to 10(-3) g/ml. Spontaneous movements of uteri of estrous or pregnant animals were depressed by HAPA-B at intravenous doses of 50 to 100 mg/kg and in in vitro at concentrations of 10(-4) to 3 X 10(-4) g/ml. Antidiuretic effect was also observed at intramuscular doses of 250 mg/kg. HAPA-B increased the length of the whole blood clotting time and raised the plasma glucose level at intramuscular doses of 1,000 mg/kg and inhibited the platelet aggregation induced by ADP in vitro at concentrations of 10(-3) g/ml.(ABSTRACT TRUNCATED AT 400 WORDS)
对新型氨基糖苷类抗生素硫酸异帕米星(HAPA - B)的一般药理学特性进行了动物实验研究,结果总结如下。肌肉注射500mg/kg剂量的HAPA - B可抑制醋酸诱导的书写反应,1000mg/kg剂量时可引起肌肉松弛、呼吸抑制、自发运动活动受抑制以及硫喷妥钠麻醉时间延长。未观察到抗惊厥作用及对直肠温度的影响。静脉注射100mg/kg剂量的HAPA - B对一般行为和中枢神经系统功能无显著影响。静脉注射HAPA - B至麻醉犬,12.5mg/kg剂量时股动脉血流量增加,25mg/kg剂量时血压下降、呼吸频率增加,50mg/kg剂量时颈动脉血流量增加。心率和心电图未见明显变化。在清醒兔中,静脉注射100mg/kg剂量的HAPA - B可使心率增加,血压和心电图无显著变化。3×10⁻⁴至10⁻³g/ml浓度的HAPA - B可抑制离体心房的自发搏动。肌肉注射500mg/kg或静脉注射100mg/kg剂量的HAPA - B可抑制胃液分泌,肌肉注射1000mg/kg剂量及3×10⁻⁴至10⁻³g/ml浓度时,分别可抑制小肠对炭末的转运及离体回肠的自发运动。对胃黏膜无刺激作用。静脉注射100mg/kg剂量的HAPA - B可抑制颈交感神经节前和节后刺激引起的瞬膜反应。体外试验中,3×10⁻⁴至10⁻³g/ml浓度的HAPA - B可非特异性抑制气管、主动脉、胃、回肠和输精管对各种激动剂的收缩反应。发情或妊娠动物静脉注射50至100mg/kg剂量及体外10⁻⁴至3×10⁻⁴g/ml浓度时,子宫的自发运动受HAPA - B抑制。肌肉注射250mg/kg剂量时也观察到抗利尿作用。肌肉注射1000mg/kg剂量的HAPA - B可延长全血凝固时间并升高血糖水平,体外10⁻³g/ml浓度时可抑制ADP诱导的血小板聚集。(摘要截于400字)